Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vapreotide

Next Previous
X
Search
Drug Profile

Vapreotide

Alternative Names: BMY-41606; Debio 8609; Docrised; RC-160; Sanvar; Sanvar IR; Sanvar SR

Latest Information Update: 12 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tulane University
  • Developer Debiovision; Salix Pharmaceuticals
  • Class Antineoplastics; Cyclic peptides; Pancreatic hormones; Pituitary hormone release inhibiting hormones
  • Mechanism of Action Somatotropin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Oesophageal varices
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acromegaly; Crohn's disease; Diarrhoea; Neuroendocrine tumours; Oesophageal varices
  • Discontinued Breast cancer; Carcinoid tumour; Liver cancer; Prostate cancer

Most Recent Events

  • 06 Feb 2019 Aralez Pharmaceuticals is now called Old API Wind-down
  • 01 Apr 2015 Salix Pharmaceuticals has been acquired by Valeant Pharmaceuticals International
  • 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top